Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
Levetiracetame
Levetiracetam
Levetiracetamum
Brand Names
Levetiracetam Extended-Release
Teva-levetiracetam
Abbott-levetiracetam
Van-levetiracetam
Jamp Levetiracetam Tablets
Levetiracetam Extended Release
Elepsia XR 1500 mg
Apo-levetiracetam
Ava-levetiracetam
Ach-levetiracetam
Levetiracetam extended-release
Levetiracetam in Sodium Chloride
Levetiracetam Sun
Bio-levetiracetam
Nat-levetiracetam
M-levetiracetam
Pdp-levetiracetam
Spritam
Riva-levetiracetam
Levetiracetam Hospira
Levetiracetam Accord
Levertiracetam
Jamp-levetiracetam
Levetiracetam
Levetiractam
Sandoz Levetiracetam
LEVETIRACETAM Extended-release
Torrent-levetiracetam
PHL-levetiracetam
Levetiracetam Levetiracetam
Nra-levetiracetam
Levetiracetam ER
Levetiracetam 1000 mg
Levetiracetam Actavis
Priva-levetiracetam
Levetiracetam Actavis Group
Keppra XR
Levetiracetam Injection USP
LEVETIRACETAM solution
Pro-levetiracetam - 750
Elepsia XR
Pro-levetiracetam - 250
Novo-levetiracetam
Ag-levetiracetam
Dom-levetiracetam
Roweepra XR
Nu-levetiracetam
Elepsia XR 1000 mg
Ran-levetiracetam
Levetiracetam Micro
Levetiracetam 750 mg
Pharma-levetiracetam
Auro-levetiracetam
Mint-levetiracetam
Roweepra
Levetiracetam Extended-release
Levetiracetam Ratiopharm
Matever
PMS-levetiracetam
Keppra
Levetiracetam 250 mg
Pro-levetiracetam - 500
Levetiracetam Teva
Indication
Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
Acetamides
Amides
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Decreased Central Nervous System Disorganized Electrical Activity
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682